ConductScience.org, home

Paper41580475

Splicing-driven post-translational dysregulation: a new frontier for precision cancer medicine and immunotherapy.

Alatawi S. Clin Transl Oncol, 2026. Cited by 1 paper, by iCite.

Cite this record

ConductScience Library. Splicing-driven post-translational dysregulation: a new frontier for precision cancer medicine and immunotherapy. Papers, record 41580475. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41580475

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Splicing-driven post-translational dysregulation: a new frontier for precision cancer medicine and immunotherapy.
PubMed
Journal
Clin Transl Oncol
PubMed
Year
2026
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
1
iCite
Revised in PubMed
2026-08-13
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Alatawi SSaelhttps://orcid.org/0000-0001-5773-5567

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
NeoplasmsMajor topic
Protein Processing, Post-TranslationalMajor topic
ImmunotherapyMajor topic
Precision MedicineMajor topic
RNA SplicingMajor topic
Humans
Mutation
Spliceosomes

Source PubMed

Download CSV of topics

References105

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
137591942Myelodysplastic neoplasm-associated U2AF1 mutations induce host defense defects by compromising neutrophil chemotaxis.Leukemia2023https://conductscience.org/library/papers/37591942PubMed
239067088FUBP1 in human cancer: Characteristics, functions, and potential applications.Transl Oncol2024https://conductscience.org/library/papers/39067088PubMed
331611195Altered RNA Processing in Cancer Pathogenesis and Therapy.Cancer Discov2019https://conductscience.org/library/papers/31611195PubMed
436974895Potential role of exitron-containing homeobox genes in cancer.WIREs Mech Dis2023https://conductscience.org/library/papers/36974895PubMed
510556814A soluble form of CTLA-4 generated by alternative splicing is expressed by nonstimulated human T cells.Eur J Immunol1999https://conductscience.org/library/papers/10556814PubMed
636075321NLRP3 leucine-rich repeats control induced and spontaneous inflammasome activation in cryopyrin-associated periodic syndrome.J Allergy Clin Immunol2023https://conductscience.org/library/papers/36075321PubMed
722919025SRSF2 mutations in 275 cases with chronic myelomonocytic leukemia (CMML).Blood2012https://conductscience.org/library/papers/22919025PubMed
831162605Emerging roles of histone modifications and HDACs in RNA splicing.Nucleic Acids Res2019https://conductscience.org/library/papers/31162605PubMed
940315850Chromatin-bound U2AF2 splicing factor ensures exon inclusion.Mol Cell2025https://conductscience.org/library/papers/40315850PubMed
1038453895Isoform alterations in the ubiquitination machinery impacting gastrointestinal malignancies.Cell Death Dis2024https://conductscience.org/library/papers/38453895PubMed
1139557344Exploring the landscape of post-translational modification in drug discovery.Pharmacol Ther2025https://conductscience.org/library/papers/39557344PubMed
1230872362Secreted PD-L1 variants mediate resistance to PD-L1 blockade therapy in non-small cell lung cancer.J Exp Med2019https://conductscience.org/library/papers/30872362PubMed
1339146933Molecular impact of mutations in RNA splicing factors in cancer.Mol Cell2024https://conductscience.org/library/papers/39146933PubMed
1429395063The Augmented R-Loop Is a Unifying Mechanism for Myelodysplastic Syndromes Induced by High-Risk Splicing Factor Mutations.Mol Cell2018https://conductscience.org/library/papers/29395063PubMed
1534339852Decoding Post-Translational Modification Crosstalk With Proteomics.Mol Cell Proteomics2021https://conductscience.org/library/papers/34339852PubMed
1629577277Alternative splice variants of DCLK1 mark cancer stem cells, promote self-renewal and drug-resistance, and can be targeted to inhibit tumorigenesis in kidney cancer.Int J Cancer2018https://conductscience.org/library/papers/29577277PubMed
1740273911Mis-splicing-derived neoantigens and cognate TCRs in splicing factor mutant leukemias.Cell2025https://conductscience.org/library/papers/40273911PubMed
1827211273Cryptic splicing events in the iron transporter ABCB7 and other key target genes in SF3B1-mutant myelodysplastic syndromes.Leukemia2016https://conductscience.org/library/papers/27211273PubMed
1931693891Aryl Sulfonamides Degrade RBM39 and RBM23 by Recruitment to CRL4-DCAF15.Cell Rep2019https://conductscience.org/library/papers/31693891PubMed
2037007111SF3B1 mutations in myelodysplastic syndromes: A potential therapeutic target for modulating the entire disease process.Front Oncol2023https://conductscience.org/library/papers/37007111PubMed

See all 105 referencesDownload CSV of references

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.

PMIDTitleJournalYearIn Papers
42266677Enhancing targeted strategies for cancer immunotherapy by elucidating mRNA processing mechanisms.Front Immunol2026https://conductscience.org/library/papers/42266677

Source PubMed

Download CSV of cited by

Genes4

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
SF3B123451PubTator's text mininghttps://conductscience.org/library/genes/23451NCBI Gene
SRSF26427PubTator's text mininghttps://conductscience.org/library/genes/6427NCBI Gene
U2AF17307PubTator's text mininghttps://conductscience.org/library/genes/7307NCBI Gene
ZRSR28233PubTator's text mininghttps://conductscience.org/library/genes/8233NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41580475

GET https://conductscience.org/api/papers/v1/41580475/references?page=2